Stem Cell Century
WARNING
You are viewing an older version of the Yalebooks website. Please visit out new website with more updated information and a better user experience: https://www.yalebooks.com
Law and Policy for a Breakthrough Technology
Russell Korobkin with Stephen R. Munzer
View Inside
Format: ClothPrice: $29.95
Out of Print
Listen to an interview with the author on the Yale Press Podcast.
A timely and provocative analysis of the broad range of policy issues raised by stem cell science and how lawmakers should address them
The explosion of interest in stem cell research raises a raft of controversial policy questions. When should human embryos be used to create stem cells? Should cloning be outlawed? Should egg and tissue donors be paid? Should we allow scientists to patent stem cells? Is the government entitled to a portion of the revenue from stem cell technology created with public funds? How should the regulators and courts balance the competing goals of access to revolutionary treatments and protection of the public from unknown risks?
Russell Korobkin, with contributions from Stephen R. Munzer, provides the first thorough discussion and analysis of these and other unsettled questions of law, policy, and ethics that surround stem cell science. His clear and concise description of complex problems coupled with logical and well-balanced conclusions makes this volume essential reading for all Americans, general readers and experts alike, interested in the promise of stem cell research and the future of regenerative medicine.
Russell Korobkin is a professor of law at the UCLA School of Law and senior fellow at the UCLA Center for Society and Genetics.
Stephen R. Munzer is also a professor of law at the UCLA School of Law and senior fellow at the UCLA Center for Society and Genetics.
Visit the author's website, StemCellCentury.com.Watch the author's recent panel discussion on the topic, covered by CSPAN's BookTV.
Co-hosted by the Harvard Stem Cell Institute and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the panelists include: Brock C. Reeve of the Harvard Stem Cell Institute; Francis Kamm and Kevin Eggan of Harvard University; and Pamela Samuelson of the University of California, Berkeley.
Publication Date: November 28, 2007
